ERIC C HSU
CIK 1817867 · Sr. VP, Pre-Clinical Res/Dev · last filed 2025-12-19
ERIC C HSU is a Sr. VP, Pre-Clinical Res/Dev who has filed 14 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for INM, was dated Dec 19, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
14
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INM | Sr. VP, Pre-Clinical Res/Dev | — | $1.51 | — | $0 | 14 | 2025-12-19 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-19 | INM | Grant (A) | — | $0 | EDGAR |
| 2025-12-17 | INM | H | — | $0 | EDGAR |
| 2024-12-23 | INM | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | INM | H | — | $0 | EDGAR |
| 2024-03-05 | INM | H | — | $0 | EDGAR |
| 2023-12-26 | INM | Grant (A) | — | $0 | EDGAR |
| 2023-08-31 | INM | H | — | $0 | EDGAR |
| 2023-05-16 | INM | H | — | $0 | EDGAR |
| 2023-03-09 | INM | H | — | $0 | EDGAR |
| 2022-12-19 | INM | Grant (A) | — | $0 | EDGAR |